ETF Components for BIB - ProShares Ultra Nasdaq Biotechnology


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
AMGN B 0.66 6.45
VRTX C 0.15 5.72
REGN C 0.51 5.69
GILD F 0.27 5.17
MRNA C 6.10 3.42
AZN A 0.27 3.29
BIIB C 0.44 2.34
ALNY C 0.56 1.41
ILMN F -2.29 1.29
BMRN F -0.66 1.13
VTRS D 0.82 1.03
SNY B -0.51 1.01
NBIX C -0.45 1.01
RPRX F 0.77 0.92
SRPT C -0.42 0.91
UTHR B 0.15 0.90
ARGX D -1.16 0.88
INCY F 0.16 0.88
MEDP D 1.00 0.87
BNTX C 2.05 0.64
ASND D -0.04 0.56
PCVX D 1.82 0.53
JAZZ F -0.34 0.51
BGNE C 0.85 0.50
BPMC B -0.67 0.49
CYTK D 1.80 0.49
ITCI C 0.49 0.48
EXEL F 0.72 0.48
RVMD C 1.57 0.46
IONS F 3.78 0.43
HALO B 0.58 0.39
APLS F 4.62 0.37
BBIO D -1.89 0.36
KRYS D 0.21 0.33
IMVT F 0.55 0.32
ALPN A 0.00 0.31
CRSP F -1.33 0.31
ALKS F 0.95 0.30
MDGL D 5.47 0.30
NUVL D 0.07 0.29
INSM D 3.11 0.28
LEGN F 0.60 0.27
IOVA D 1.07 0.27
SMMT B 2.25 0.26
CRNX B -1.52 0.26
AXSM D 1.36 0.26
RARE F -0.81 0.25
XENE D 1.56 0.24
IDYA D -0.44 0.23
SWTX D -5.31 0.23
ARWR F 0.20 0.23
FTRE D -2.32 0.23
FOLD F 1.88 0.22
JANX C 1.89 0.21
ACAD F 2.10 0.21
MRUS C -0.64 0.20
ACLX F 1.38 0.20
DNLI F -1.85 0.19
TWST B -4.55 0.18
GH C -2.33 0.17
VCEL B 5.75 0.17
RYTM D 2.63 0.17
KYMR D 3.03 0.17
VERA C -0.97 0.17
PTCT C 21.23 0.17
MYGN A -1.11 0.16
ARVN F 1.77 0.16
NTLA F -1.26 0.16
AMPH F -0.94 0.15
DCPH A 0.04 0.15
RNA B -0.88 0.15
RCKT F 0.93 0.15
GERN C -2.10 0.15
DYN D 27.82 0.15
SANA D -1.15 0.15
KROS D 0.17 0.15
IMCR F -0.26 0.15
SNDX D -0.20 0.14
EWTX C 3.64 0.14
RXRX F 3.82 0.14
ARDX C 1.54 0.14
SUPN F -1.13 0.13
NVCR C 9.37 0.13
HRMY F 2.38 0.13
BEAM F 0.89 0.13
AGIO C -3.35 0.13
PTGX C 1.69 0.12
INBX D -0.69 0.12
DAWN C -1.24 0.11
XNCR C 3.13 0.11
MORF F 4.04 0.11
VCYT D -2.53 0.11
DVAX F 2.52 0.11
FUSN A 0.09 0.11
KURA C 0.32 0.11
ADMA B 2.17 0.11
FDMT D 2.60 0.10
PCRX D -0.68 0.10
ANIP C 0.49 0.10
LGND B 0.66 0.10
MIRM F 5.11 0.09
MRVI C 0.18 0.09
AKRO F 1.10 0.09
CGEM C 3.50 0.09
MNKD D 2.40 0.09
GMAB F -0.97 0.09
COLL D 5.17 0.09
PRTA F 0.49 0.09
IRWD F -0.93 0.09
TARS B 1.28 0.09
VIR F -0.41 0.09
SRRK D 0.24 0.08
BCRX D -2.39 0.08
ABCL F 2.75 0.08
MGNX F -2.41 0.07
INVA B 0.94 0.07
ELVN B 4.17 0.07
VRNA F -1.69 0.07
EOLS D -1.25 0.06
ARQT D 1.63 0.06
COGT C 5.38 0.06
PLRX F -0.98 0.06
KNSA C -0.51 0.06
ZLAB C 7.42 0.06
ALXO C -2.96 0.06
GRFS C -0.26 0.06
ETNB F 3.59 0.06
BCYC D 1.64 0.06
RLAY F 2.11 0.06
SPRY C 1.77 0.06
ZNTL F -2.32 0.06
PRME F 6.36 0.05
NVAX B 13.68 0.05
OCUL D 1.94 0.05
LYEL C -2.55 0.05
CVAC F -2.58 0.05
ORIC F -0.87 0.05
CSTL B 2.89 0.05
SVRA D -6.92 0.05
NRIX D -2.41 0.05
ANAB C -0.24 0.05
IRON F 0.59 0.05
WVE D 1.92 0.05
ARCT F 2.42 0.05
RGNX F -0.75 0.05
AUPH F 0.35 0.05
SAGE F -4.44 0.05
ALEC F -0.55 0.04
KALV C -0.34 0.04
VERV F -0.50 0.04
PETQ B 0.90 0.04
CABA F 4.29 0.04
TVTX F 1.82 0.04
OABI D -1.35 0.04
SIGA C -0.79 0.04
CNTA D -1.69 0.04
EYPT F 2.53 0.04
GLPG F -1.52 0.04
PHAT D 3.32 0.04
AUTL F -8.43 0.04
YMAB D 1.90 0.04
OLMA F -3.25 0.04
MLYS B -1.46 0.04
HCM A -0.40 0.04
PAHC A -0.92 0.03
HROW D 0.18 0.03
TERN F 5.93 0.03
RVNC F 4.64 0.03
BMEA F 3.10 0.03
URGN F -2.34 0.03
REPL F -7.76 0.03
EDIT F -1.78 0.03
LXRX D 0.00 0.03
ITOS B 0.22 0.03
TSHA D 0.00 0.03
PACB F -4.95 0.03
ADPT C -0.55 0.03
ALLO F -6.50 0.03
VYGR D 0.24 0.03
HUMA B 11.53 0.03
FULC D 1.99 0.03
TBPH C -2.05 0.03
ABUS B 3.02 0.03
THRD B 3.86 0.03
OVID F -0.32 0.02
ACIU F -0.63 0.02
QURE F -3.19 0.02
CHRS F -1.89 0.02
XERS F 3.54 0.02
VTYX F 2.11 0.02
RAPT F -0.99 0.02
AVXL F -2.64 0.02
VNDA B -3.83 0.02
CRBU F -7.67 0.02
ERAS F 13.71 0.02
MGTX F -2.98 0.02
PGEN F 0.72 0.02
AMRN F 1.14 0.02
ATAI C 1.17 0.02
MRNS F 1.50 0.01
ACRS F 0.00 0.01
ME D -6.85 0.01
BLUE F 0.00 0.01
RPHM D 8.57 0.00

Recent News for ProShares Ultra Nasdaq Biotechnology & its Holdings

Date Stock Title
May 21 AMGN Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript)
May 20 DYN Why Is Dyne Therapeutics Stock Soaring On Monday?
May 20 MRNA Aggressive Strides Forward For Moderna's Cancer Vaccine
May 20 SNY Sanofi: Information concerning the total number of voting rights and shares - April 2024
May 20 INSM Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Co...
May 20 DYN Dyne Therapeutics announces underwritten proposed offering of common stock
May 20 NRIX Nurix Therapeutics announces Julia P. Gregory as new board Chair
May 20 ILMN Anna Richo joins Illumina's Board of Directors
May 20 PAHC Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference
May 20 NRIX Nurix Therapeutics Announces Board Chair Transition
May 20 MRNA Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
May 20 AMGN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
May 20 NVAX Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
May 20 MRNA Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
May 20 ARQT Arcutis Stock: Sales Expansion Momentum Puts It On A Good Trajectory
May 20 SNY Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
May 20 REGN Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
May 20 LGND BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
May 20 ANIP BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq 100 Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
Back to the Main BIB Page...